SHC - Sotera Health Company Short-Term Debt to Capital

soterahealth.com - graphic logo of issuer SHC

Sotera Health Company (SHC) faces multi-billion dollar claims over harmful emissions and pressure from environmentalists amid its debt burden. The business relies on a niche sterilization market with high barriers to entry, where competition for contracts with pharma behemoths is intense. This price action chart reflects the 0.39 indicator. High customer loyalty within this ecosystem maintains stability despite ongoing litigation and stringent regulations.

Short-Term Debt to Capital Ratio: Sotera Health Corp (SHC) for 07/04/2022 - 11/01/2026

Analytical breakdowns for soterahealth.com (SHC)

- stock quotes and analyst forecast:
Stock Price Sterigenics|SHC - Broker Consensus Forecast
- market capitalization statistics:
Market Capitalization Sotera Health Corp|SHC - Enterprise Value
- book capitalization information:
Net Assets per Single Share Sotera Health|SHC - Accounting Capitalization|Market Capitalization to Book Value Ratio soterahealth.com|SHC - Company Total Assets
- company liabilities and liquidity data:
Debt to Equity Sotera Health Company|SHC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Sotera Health|SHC - Company Cumulative Debt|Debt to Book Capitalization Ratio Sotera Health Corp|SHC - Long-Term Debt Volume|Company Short-Term Debts Sotera Health|Quick Liquidity soterahealth.com
- company profitability and valuation multiples indicators:
SHC - Net Financial Result
Analysis of all company metrics:SHC Sterigenics
Signature product of Sotera Health Corp

This ratio compares liabilities with a maturity of up to one year against equity, determining the extent of liquidity dependence on short-term borrowing. For Sotera Health Company (SHC), the short-term debt to equity chart is critically important, as legal costs related to ethylene oxide emissions may necessitate a sharp increase in working capital, creating risks of cash flow gaps.

Main competitors

Short-Term Debt to Capital A|Quest Corp - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital ILMN (Illumina, Inc.)|Short-Term Debt to Capital exactsciences.com EXAS|RVTY - Short-Term Debt to Equity|BIO (Bio-Rad Laboratories, Inc.) - Short-Term Debt to Capital Ratio|NNNN: Short-Term Debt to Capital|QuidelOrtho Inc. (QDEL) - Short-Term Debt to Capital|Short-Term Debt to Equity OPKO Health, Inc.|Short-Term Debt to Equity CDNA|Short-Term Debt to Equity Ratio MRVI (Maravai LifeSciences Holdings, Inc.)|FLGT - Current Liabilities to Capital|Short-Term Debt to Equity Fluidigm LAB|Short-Term Debt to Capital Coefficient Cytek Corp (CTKB)|OraSure Technologies - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Exagen Inc. XGN|MDxHealth (MDXH) - Short-Term Debt to Equity|LUCD - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Prenetics Global Limited|Insight Molecular (IMDX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Trinity Biotech plc (TRIB)|PRPH - Current Liabilities to Capital|Ainos - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio CODX (Co-Diagnostics Inc)|Heart Test Laboratories Inc. - Short-Term Debt to Capital|Current Liabilities to Capital Biomerica Inc|cardiodiagnosticsinc.com (CDIO) - Short-Term Debt to Equity|viraxbiolabs.com - Ratio of Short-Term Indebtedness to Capital|BJDX (Bluejay Diagnostics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Aspira Women's Health, Inc.|Short-Term Debt to Equity Ratio AXDX (Accelerate Diagnostics, Inc)|CNTG (Centogene) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ENZ (Enzo Biochem)|Ratio of Short-Term Indebtedness to Capital FRES|GTG Labs - Short-Term Debt to Capital|Current Liabilities to Capital 23andMe Holding Co|PMD: Short-Term Debt to Capital